Category Archives: study

  1. Study – Addressing Social Drivers of HIV/AIDS for the Long-Term Response: Conceptual and methodological Considerations

    Via MSMGF. A key component of the shift from an emergency to a long-term response to AIDS is a change in focus from HIV prevention interventions focused on individuals to a comprehensive strategy in which social/structural approaches are core elements. Such approaches aim to modify social conditions by addressing key drivers of HIV vulnerability that affect the Read More >>

    behavioral research, HIV, HIV/AIDS, HIV/AIDS policy, prevention, sexual behavior, social conditions, study
  2. Bacterial Bioshield Could Keep HIV at Bay

    Via New Scientist. A LIVING microbicide reduces HIV-like infection in monkeys, and might one day provide women with long-lasting defence against the virus. Dean Hamer of the National Institutes of Health in Bethesda, Maryland, and colleagues engineered naturally occurring vaginal bacteria to produce the anti-HIV protein cyanovirin-N. They applied a gel containing the bacteria to the vaginas Read More >>

    bacteria, clinical trials, HIV transmission, HIV/AIDS, Microbicides, prevention, study
  3. Washington D.C.: Public Meeting on Safety Issues in PrEP

    An invitation from the Forum for Collaborative HIV Research: Safety Issues in Pre-exposure Prophylaxis for HIV negative individuals, proposals for management of safety concerns, and pending plans for scale-up Forum for Collaborative HIV Research 1608 Rhode Island Avenue, NW Washington, DC 20036 August 19, 2011 8:30am – 4:00pm The Forum for Collaborative HIV Research has been tasked Read More >>

    Forum for Collaborative HIV Research, HIV/AIDS, iPrEx, new prevention technologies, Partners PrEP, pre-exposure prophylaxis, PrEP, prevention, safety, study, TDF2
  4. New, Long-Term PrEP Study Announced

    Via Now Chelsea, by Sam Spokony. Few methods of HIV prevention have been as promising, or as controversial, as pre-exposure prophylaxis (PrEP). After a history of underground practice and off-label prescriptions, the approach has recently begun to receive serious attention from researchers, policy makers and health care advocates. An outgrowth of post-exposure prophylaxis (or PEP, a short-term Read More >>

    clinical trials, FTC, HIV/AIDS, iPrEx, maraviroc, new prevention technologies, pre-exposure prophylaxis, PrEP, prevention, Selzentry, study, Tenofovir, Treatment as Prevention, Truvada